Patents by Inventor Deborra Mullins

Deborra Mullins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Neuropeptide receptor modulators
    Publication number: 20060089351
    Abstract: The present invention discloses compounds, which are novel receptor antagonists for NPY Y1 as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such NPY Y1 receptor antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.
    Type: Application
    Filed: April 28, 2005
    Publication date: April 27, 2006
    Inventors: Zhaoning Zhu, Zhong-Yue Sun, Yuanzan Ye, Deborra Mullins, Brian McKitrtick, Andrew Stamford, William Greenlee
  • Inhibitors of platelet-derived growth factor
    Patent number: 5238950
    Abstract: A method of inhibiting the binding of PDGF using compounds of the formula I ##STR1## useful in the treatment of atherosclerosis, cancer, retinal detachment, pulmonary fibrosis, arthritis, psoriasis and glomerulonephritis, and restenosis following angioplasty or vascular surgery is disclosed.Also disclosed are pharmaceutical compositions and novel PDGF inhibitory compounds of the formula ##STR2## or a pharmaceutically acceptable addition salt thereof, useful in the treatment of atherosclerosis, cancer, retinal detachment, pulmonary fibrosis, arthritis, psoriasis and glomerulonephritis, and restenosis following angioplasty or vascular surgery.
    Type: Grant
    Filed: December 17, 1991
    Date of Patent: August 24, 1993
    Assignee: Schering Corporation
    Inventors: John W. Clader, Harry R. Davis, Deborra Mullins, Stuart Rosenblum, Jay Weinstein